Andlauer Healthcare Group Inc. (TSE:AND) Forecasted to Earn Q2 2024 Earnings of $0.45 Per Share

Andlauer Healthcare Group Inc. (TSE:AND) – Equities researchers at Stifel Canada reduced their Q2 2024 earnings per share (EPS) estimates for Andlauer Healthcare Group in a note issued to investors on Tuesday, July 23rd. Stifel Canada analyst J. Keywood now anticipates that the company will earn $0.45 per share for the quarter, down from their previous estimate of $0.47. The consensus estimate for Andlauer Healthcare Group’s current full-year earnings is $1.64 per share. Stifel Canada also issued estimates for Andlauer Healthcare Group’s Q3 2024 earnings at $0.46 EPS, Q4 2024 earnings at $0.52 EPS and FY2024 earnings at $1.73 EPS.

Andlauer Healthcare Group (TSE:AND) last issued its earnings results on Thursday, May 2nd. The company reported C$0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). The firm had revenue of C$161.14 million during the quarter, compared to the consensus estimate of C$168.50 million. Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%.

Several other equities research analysts also recently commented on the stock. CIBC decreased their target price on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research report on Monday, May 6th. Stifel Nicolaus lowered their price objective on Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. Royal Bank of Canada cut their target price on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating on the stock in a research report on Monday, May 6th. TD Securities decreased their price target on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a report on Monday, May 6th. Finally, Scotiabank cut Andlauer Healthcare Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 14th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of C$49.43.

Andlauer Healthcare Group Stock Performance

AND opened at C$40.54 on Thursday. Andlauer Healthcare Group has a 1-year low of C$36.43 and a 1-year high of C$44.76. The company has a market cap of C$789.72 million, a price-to-earnings ratio of 26.85 and a beta of 0.69. The company’s fifty day moving average price is C$38.79 and its two-hundred day moving average price is C$40.29. The company has a current ratio of 1.94, a quick ratio of 1.66 and a debt-to-equity ratio of 26.06.

Insider Buying and Selling at Andlauer Healthcare Group

In other news, Director Ronald Martin Skelton sold 1,500 shares of Andlauer Healthcare Group stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of C$40.87, for a total transaction of C$61,309.95. Corporate insiders own 1.43% of the company’s stock.

Andlauer Healthcare Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Shareholders of record on Friday, June 28th were given a $0.10 dividend. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.40 annualized dividend and a yield of 0.99%. Andlauer Healthcare Group’s dividend payout ratio is currently 23.84%.

About Andlauer Healthcare Group

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.